1. Home
  2. NUVL vs AEIS Comparison

NUVL vs AEIS Comparison

Compare NUVL & AEIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVL
  • AEIS
  • Stock Information
  • Founded
  • NUVL 2017
  • AEIS 1981
  • Country
  • NUVL United States
  • AEIS United States
  • Employees
  • NUVL N/A
  • AEIS N/A
  • Industry
  • NUVL Biotechnology: Pharmaceutical Preparations
  • AEIS Industrial Machinery/Components
  • Sector
  • NUVL Health Care
  • AEIS Technology
  • Exchange
  • NUVL Nasdaq
  • AEIS Nasdaq
  • Market Cap
  • NUVL 7.1B
  • AEIS 8.2B
  • IPO Year
  • NUVL 2021
  • AEIS 1995
  • Fundamental
  • Price
  • NUVL $109.19
  • AEIS $189.21
  • Analyst Decision
  • NUVL Strong Buy
  • AEIS Strong Buy
  • Analyst Count
  • NUVL 13
  • AEIS 9
  • Target Price
  • NUVL $133.85
  • AEIS $210.22
  • AVG Volume (30 Days)
  • NUVL 734.4K
  • AEIS 551.0K
  • Earning Date
  • NUVL 10-30-2025
  • AEIS 11-04-2025
  • Dividend Yield
  • NUVL N/A
  • AEIS 0.21%
  • EPS Growth
  • NUVL N/A
  • AEIS 236.95
  • EPS
  • NUVL N/A
  • AEIS 3.81
  • Revenue
  • NUVL N/A
  • AEIS $1,724,842,000.00
  • Revenue This Year
  • NUVL N/A
  • AEIS $19.29
  • Revenue Next Year
  • NUVL N/A
  • AEIS $7.24
  • P/E Ratio
  • NUVL N/A
  • AEIS $49.53
  • Revenue Growth
  • NUVL N/A
  • AEIS 17.19
  • 52 Week Low
  • NUVL $55.54
  • AEIS $75.01
  • 52 Week High
  • NUVL $112.88
  • AEIS $232.05
  • Technical
  • Relative Strength Index (RSI)
  • NUVL 66.08
  • AEIS 41.56
  • Support Level
  • NUVL $93.05
  • AEIS $193.22
  • Resistance Level
  • NUVL $112.53
  • AEIS $222.92
  • Average True Range (ATR)
  • NUVL 5.84
  • AEIS 11.13
  • MACD
  • NUVL 1.06
  • AEIS -3.74
  • Stochastic Oscillator
  • NUVL 84.34
  • AEIS 1.00

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About AEIS Advanced Energy Industries Inc.

Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.

Share on Social Networks: